Latest news with #AIIMSBilaspur
Time of India
11-07-2025
- Time of India
32 injured as bus rolls down hill in Bilaspur
Shimla: A total of 32 devotees were injured after a private bus they were travelling in rolled down a hill near Namloh village in Bilaspur district in the early hours of Friday. The devotees were returning to Darlaghat after attending a religious function held on the occasion of Guru Purnima in Nurmahal, Punjab. There were 36 passengers on board at the time of the accident, most of whom belonged to Darlaghat in Solan district. The locals were the first to reach the accident spot and inform the police and emergency services. They also helped to take out the injured from the bus. A police officer said all the injured were taken to AIIMS Bilaspur and other govt hospitals in Bilaspur. The officer mentioned that the police were inquiring into the cause of the accident. Meanwhile, CM Sukhvinder Singh Sukhu visited AIIMS in Bilaspur to enquire about the well-being of the injured . He met the injured and assured them of all possible assistance. The CM directed the hospital administration to ensure prompt and best medical care for the injured.
CTV News
11-07-2025
- Health
- CTV News
Cancer patient's grey hair ‘turned black gradually' during therapy, study says
A cancer drug used to treat advanced kidney cancer appears to have reversed grey hair in an older man, a rare side effect that researchers say could offer new clues about how hair colour might be restored. Researchers at the All India Institute of Medical Sciences, Bilaspur (AIIMS Bilaspur), published the study in BMJ Case Reports on June 27. It describes a man in his late 60s who was being treated for metastatic renal cell carcinoma with axitinib, a targeted cancer drug. After six months on the medication, his hair began changing colour. 'The patient observed that the hair on his moustache and scalp, which had previously turned grey due to ageing, turned black gradually, starting from the margins of the hairline on the scalp,' study authors Avita Dhiman, Pravesh Dhiman and Manju Daroach wrote. Grey hair study (a) Blackening of moustache hair and (b) blackening of scalp hair. Credit: BMJ Publishing Group Limited 2025. They added the effect continued to progress over the following months without the use of hair dye or other treatments. Axitinib belongs to a class of cancer therapies known as tyrosine kinase inhibitors (TKIs), which block specific cell signals that promote tumour growth. In this case, researchers believe the drug also triggered melanogenesis, the process that produces melanin, the pigment responsible for hair, skin and eye colour. 'Although several TKIs have been associated with hair repigmentation, this appears to be the first documented case of axitinib-induced hair repigmentation,' the authors wrote. They point to axitinib's role in blocking signalling pathways linked to pigment production, saying the drug may help protect the cells that produce melanin from damage and promote a key enzyme in melanin synthesis. The man's hair gradually darkened from the front of his scalp toward the back, with more of the occipital region turning black by the end of the ninth month. Despite the unusual side effect, doctors chose to continue the cancer treatment because the patient was responding well to it. 'Our hair … has some degree of melanin to give it its colour, otherwise it would be white or grey,' explained Dr. Monica Li, clinical assistant professor with the Department of Dermatology and Skin Science at the University of British Columbia, in a video interview with grey hair study Blackening of hair started from the hairline. Credit: BMJ Publishing Group Limited 2025 'As we get older, stress, certain medications, poor diet, vitamin deficiencies … could decrease how robust hair growth is, but also the colour,' she said. 'That's why as we get older people show gray and white hair, because the melanin production is less.' Li cautioned, however, that while the case is intriguing, it remains an isolated finding. 'It is a case report, meaning it's a sample size of one,' she said, adding there need to be more reports to confirm if this is 'a consistent observation.' Li says hair colour changes have been observed with other TKIs, such as sorafenib, and the effect is often temporary, meaning that once the patient stops taking the drug, the hair tends to return to its original state. The researchers also acknowledge that hair colour changes aren't unheard of with cancer drugs, saying up to 30 per cent of people receiving targeted therapies may notice some kind of pigmentation shift. While the greying reversal was not the intended goal of treatment, researchers say it's a sign of how certain drugs may influence biological systems far beyond cancer. 'The observation … could have broader implications for understanding their role in non-cancer-related processes, reversing grey hair and developing specific drugs … which may be used to reverse greying of hair,' the authors conclude. grey hair study (a) Blackening of hair over the occipital area and (b) follow-up after 2 months revealed that more hair had turned black. Credit: BMJ Publishing Group Limited 2025 But Li emphasized that the drug in question is not something to be taken lightly. 'This is an anti-cancer medication,' she said, warning that there are serious potential side effects, from high blood pressure and diarrhea to rare, but life-threatening events like hypertensive crisis and blood clots. 'We have to understand that in general, medications have their advantages and disadvantages, and all medications have side effects,' Li explained. 'Some are common, some are not so common, but the uncommon ones are devastating and life-threatening.' She added that while repigmentation may seem like a cosmetic bonus for patients already undergoing cancer treatment, the risks of using such a drug solely for reversing grey hair would far outweigh the benefits. 'We all age and it's totally normal to see changes in the colour of our hair,' Li said. 'We're far, far away from even considering using an anti-cancer medication, just so that we can have hair greying improve.'
Time of India
07-07-2025
- Health
- Time of India
Himachal: AIIMS Bilaspur sets target to make state self-reliant in healthcare
Bilaspur: The All India Institute of Medical Science (AIIMS) Bilaspur is all set to make Himachal Pradesh a self-reliant state in health care. The AIIMS Bilaspur Director, Prof DN Sharma, shared significant milestones of the institute's progress with the media on Sunday, highlighting rapid infrastructure expansion, medical breakthroughs, and a focused drive toward cancer research and trauma care. In just less than three years since its inception, AIIMS Bilaspur has increased its inpatient capacity from 690 to 728 beds, catering to over 1,500 patients daily, with more than 4,000 indoor admissions every month. The institute also recorded its first successful kidney transplant, a major achievement in its clinical journey. Over 30,000 patients are being treated monthly, and the hospital has developed a strong community outreach programme, backed by interdisciplinary collaborations and state-of-the-art equipment, including an MRI facility. AIIMS Bilaspur is equipped with four times more ventilators than other hospitals in Himachal Pradesh, ensuring robust emergency preparedness. With a strong academic backbone, the institute now has 620 students, including 100 MBBS seats, and offers 17 broad specialities. However, Prof. Sharma noted that some faculty positions in medical gastroenterology remain vacant, though recruitment drives are ongoing. Cancer care remains a major focus area, with work underway for a dedicated Trauma Centre, and a proposal for Phase 2 expansion valued at Rs 178.05 crore. A feasibility survey for Rs 332 crore has also been conducted to support future developments, including enhanced cancer treatment infrastructure. AIIMS Bilaspur is also actively participating in ICMR-backed research projects on breast and cervical cancer and has seen high utilisation in its radiation oncology department, treating 83 patients regularly, with daily attendance ranging from 20 to 30 patients, nearing 900 total so far. Prof Sharma emphasised lifestyle-related cancers and rising cases such as lung cancer, along with Delhi topping the chart for prostate cancer prevalence. AIIMS Bilaspur is also expected to soon be equipped with PET scan and titration control facilities to enhance diagnostic precision. AIIMS Bilaspur is now among the fastest-growing AIIMS in the country, both in terms of infrastructure and services and aims to ensure that people in the region no longer need to travel outside Himachal Pradesh for advanced treatment. (ANI)
India Gazette
06-07-2025
- Health
- India Gazette
Himachal: AIIMS Bilaspur sets target to make state self-reliant in healthcare
Bilaspur (Himachal Pradesh) [India], July 6 (ANI): The All India Institute of Medical Science (AIIMS) Bilaspur is all set to make Himachal Pradesh a self-reliant state in health care. The AIIMS Bilaspur Director, Prof DN Sharma, shared significant milestones of the institute's progress with the media on Sunday, highlighting rapid infrastructure expansion, medical breakthroughs, and a focused drive toward cancer research and trauma care. In just less than three years since its inception, AIIMS Bilaspur has increased its inpatient capacity from 690 to 728 beds, catering to over 1,500 patients daily, with more than 4,000 indoor admissions every month. The institute also recorded its first successful kidney transplant, a major achievement in its clinical journey. Over 30,000 patients are being treated monthly, and the hospital has developed a strong community outreach programme, backed by interdisciplinary collaborations and state-of-the-art equipment, including an MRI facility. AIIMS Bilaspur is equipped with four times more ventilators than other hospitals in Himachal Pradesh, ensuring robust emergency preparedness. With a strong academic backbone, the institute now has 620 students, including 100 MBBS seats, and offers 17 broad specialities. However, Prof. Sharma noted that some faculty positions in medical gastroenterology remain vacant, though recruitment drives are ongoing. Cancer care remains a major focus area, with work underway for a dedicated Trauma Centre, and a proposal for Phase 2 expansion valued at Rs 178.05 crore. A feasibility survey for Rs 332 crore has also been conducted to support future developments, including enhanced cancer treatment infrastructure. AIIMS Bilaspur is also actively participating in ICMR-backed research projects on breast and cervical cancer and has seen high utilisation in its radiation oncology department, treating 83 patients regularly, with daily attendance ranging from 20 to 30 patients, nearing 900 total so far. Prof Sharma emphasised lifestyle-related cancers and rising cases such as lung cancer, along with Delhi topping the chart for prostate cancer prevalence. AIIMS Bilaspur is also expected to soon be equipped with PET scan and titration control facilities to enhance diagnostic precision. AIIMS Bilaspur is now among the fastest-growing AIIMS in the country, both in terms of infrastructure and services and aims to ensure that people in the region no longer need to travel outside Himachal Pradesh for advanced treatment. (ANI)
Time of India
08-06-2025
- Health
- Time of India
Latest heart op techniques, using AI & robots, discussed at docs' global meet
Chandigarh: Doctors and experts from around the world gathered for the 15th Cardiomersion Global Conference, a three-day annual event, which concluded recently. Held in both Chandigarh, India, and Rome, Italy, the conference brought together more than 100 leading heart specialists to discuss the latest approaches to treating heart diseases. Tired of too many ads? go ad free now The conference was a significant opportunity for doctors to share their latest findings and discuss cutting-edge technologies and advanced surgical techniques. The main objective was to find better ways to help patients with heart problems, making treatments more effective and less invasive. Dr Deepak Puri, who leads the Cardiomersion organisation globally, gave two highly anticipated talks. In one, he introduced a new and improved way to perform chest surgeries called uniportal video-assisted thoracoscopic surgery (UVATS). This technique allows doctors to perform complex operations through a tiny, single three-centimetre cut. Dr Puri explained that this new method is almost as clear to see as traditional open surgery, but it means much less pain, lower costs, and faster recovery for patients. Another key speaker, Dr Johannes Bonatti, a heart surgeon from Pittsburgh, US, painted an exciting picture of the future. He described how robots are increasingly being used in heart surgery, not just for simpler procedures like bypasses, but also for more complex operations like replacing heart valves and even heart and lung transplants. He discussed new surgical robots that are more flexible and offer better control, even enabling doctors to perform surgery remotely. Following this vision, Dr Eric J Lehr, another minimally invasive heart surgeon from Seattle, US, discussed how robotics, along with artificial intelligence (AI), will revolutionise heart surgery. He showed how systems like the "da Vinci" robot have made procedures like heart valve repair and bypass surgery more precise and comfortable for patients. Tired of too many ads? go ad free now Dr Nidhi Puri, professor of anatomy from AIIMS Bilaspur, shared important insights about variations in a crucial blood vessel used in heart bypass surgery. Her presentation highlighted why it's so important for doctors to carefully check a patient's anatomy before surgery to avoid problems and achieve the best results.
